apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration (2021) Hecht M, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Klautke G, Laban S, et al. Conference contribution The radiation-induced Activation of Anti-tumor Immune Mechanisms is enhanced by Inhibtion of the Heat Shock Protein 90 (2021) Ernst A, Hennel R, Krombach J, Kapfhammer H, Brix N, Zuchtriegel G, Uhl B, et al. Conference contribution Radon affects Immune Cells ex vivo as well as in vivo in an Animal Model of experimental Arthritis (2021) Deloch L, Rückert M, Maier A, Hinrichs A, Flohr AS, Eckert D, Seeling M, et al. Conference contribution Cytotoxic and immunogenic Potential of Iron (II) Clathrochelates and Irradiation on Lung Cancer Cell Lines (2021) Becker I, Denzler M, Heim L, Klemt I, Voloshin YZ, Selin R, Mokhir A, et al. Conference contribution Immunomodulatory and analgesic Effects of serial Radon-Baths in Patients with musculoskeletal Diseases: Investigations in the RAD-ON02 Study (2021) Donaubauer AJ, Becker I, Weikl L, Klein G, Fietkau R, Gaipl U, Frey B Conference contribution Establishment of a FACS Assay for Screening of (TEMRA) Cells in Glioblastoma Patients (2021) Scheer I, Becker I, Donaubauer AJ, Fietkau R, Gaipl U, Frey B Conference contribution Low-dose Radiotherapy is highly effective in the Treatment of Patients with painful Ankle Arthrosis (2021) Weissmann T, Putz F, Hecht M, Zhou J, Donaubauer AJ, Fietkau R, Gaipl U, et al. Conference contribution 12 x 6 Gy stereotactic radiotherapy for lung tumours. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021) Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R Conference contribution Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution The IMMO-LDRT01 Study - Analgesic and immunomodulatory Effects of LDRT in Patients with chronic degenerative and inflammatory Diseases (2021) Donaubauer AJ, Fröhlich B, Becker I, Weissmann T, Fietkau R, Ott O, Gaipl U, Frey B Conference contribution